N/A
Completed N=520
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Source: ClinicalTrials.gov NCT01244516 ↗Enrolled (actual)
520
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Overall Subjective Comfort — 51.7; 51.3; 51.3 CLUE score
Summary
The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Overall Subjective Comfort |
51.7; 51.3; 51.3 | — |
| PRIMARY Corneal Staining |
78.5; 67.1; 66.1; 21.5; 32.9; 33.9 | — |
| SECONDARY Overall Subjective Lens Handling |
64.3; 59.8 | — |
Eligibility Criteria
Inclusion Criteria
- Be no less than 18 and no more than 39 years of age.
- Sign Written Informed Consent and investigator to record this on Case Report Form.
- Be willing and able to adhere to the instructions set out in the protocol.
- Be an existing successful daily wear soft contact lens wearer. For the purposes of this study this means wearing lenses for at least 6 hours per day, 5 days per week for the last month.
- No extended wear in the last 3 months.
- Subjective refraction must result in a vertex corrected spherical contact lens prescription between -1.00 and -6.00 diopters.
- Have refractive astigmatism less than or equal to 1.00 diopters (D) in both eyes.
- Achieve visual acuity of 6/9 (20/30) or better in each eye.
- Require a visual correction in both eyes (no monovision allowed).
- Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: no amblyopia, no evidence of lid abnormality or infection (including blepharitis/meibomitis), no conjunctival abnormality or infection, no clinically significant slit lamp findings (i.e. stromal edema, vascularization, infiltrates or abnormal opacities), no other active ocular disease.
Exclusion Criteria
- Requires concurrent ocular medication.
- Clinically significant corneal stromal haze, corneal vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
- Clinically significant corneal staining
- Requires presbyopic correction (i.e. Not using any presbyopic correction and measured add power of less than +1.00 diopters).
- Has had refractive surgery.
- Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
- Abnormal lacrimal secretions.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Keratoconus or other corneal irregularity.
- Hard, hybrid or Rigid Gas Permeable lens wear in the previous 8 weeks.
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Diabetic.
- Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease [e.g., Human immunodeficiency virus (HIV)].
- History of chronic eye disease (e.g. glaucoma or Age Related Macular Degeneration).
- Pregnancy, lactating or planning a pregnancy at the time of enrollment.
- Participation in any concurrent clinical trial or in last 30 days
Data sourced from ClinicalTrials.gov (NCT01244516). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.